human cancer cell lines hela Search Results


95
Genecopoeia hela cells
Hela Cells, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hela cells/product/Genecopoeia
Average 95 stars, based on 1 article reviews
hela cells - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

96
AMS Biotechnology cervical cancer cell line hela
ZP3-Cancer is the dominant transcript in tumor cells and is differentially distributed among cancer types. (A) Expression of the seven annotated ZP3 transcripts in CCls (n=1339). Bars represent Tukey box plots (boxes are median+IQR). Median transcript expression levels (from left to right) are 2.47, 0.22, 0.0, 0.04, 0.42, 0.0 and 0.0 TPM. ZP3-Cancer expression is significantly higher compared to all other transcripts (Kruskal-Wallis test, p < 0.0001). NC = Non-protein coding. (B) Relative expression of ZP3-cancer and ZP3-Oocyte in the <t>CCLs</t> <t>MCF7</t> and <t>HeLa,</t> and in healthy ovarian tissue containing follicles, as determined by qPCR. ZP3-Cancer expression is set to 1 for MCF7 and HeLa, ZP3-Oocyte expression is set to 1 for ovarian tissue. ‘ZP3-both’ served as a positive control and used primers designed to detect ZP3-Cancer and ZP3-Oocyte simultaneously. Bars represent mean+SD for the triplicate qPCR reactions. (C) Differential expression of ZP3-Cancer in the cancer types covered by the CCLs. Cancer types represented by less than 5 CCLs were not included. Bars represent Tukey box plots (boxes are median+IQR). Number of samples are indicated between brackets. The shaded area indicates CCLs with a ZP3-Cancer expression level below the overall median (2.54 TPM).
Cervical Cancer Cell Line Hela, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cervical cancer cell line hela/product/AMS Biotechnology
Average 96 stars, based on 1 article reviews
cervical cancer cell line hela - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

95
Genecopoeia hela cell line
ZP3-Cancer is the dominant transcript in tumor cells and is differentially distributed among cancer types. (A) Expression of the seven annotated ZP3 transcripts in CCls (n=1339). Bars represent Tukey box plots (boxes are median+IQR). Median transcript expression levels (from left to right) are 2.47, 0.22, 0.0, 0.04, 0.42, 0.0 and 0.0 TPM. ZP3-Cancer expression is significantly higher compared to all other transcripts (Kruskal-Wallis test, p < 0.0001). NC = Non-protein coding. (B) Relative expression of ZP3-cancer and ZP3-Oocyte in the <t>CCLs</t> <t>MCF7</t> and <t>HeLa,</t> and in healthy ovarian tissue containing follicles, as determined by qPCR. ZP3-Cancer expression is set to 1 for MCF7 and HeLa, ZP3-Oocyte expression is set to 1 for ovarian tissue. ‘ZP3-both’ served as a positive control and used primers designed to detect ZP3-Cancer and ZP3-Oocyte simultaneously. Bars represent mean+SD for the triplicate qPCR reactions. (C) Differential expression of ZP3-Cancer in the cancer types covered by the CCLs. Cancer types represented by less than 5 CCLs were not included. Bars represent Tukey box plots (boxes are median+IQR). Number of samples are indicated between brackets. The shaded area indicates CCLs with a ZP3-Cancer expression level below the overall median (2.54 TPM).
Hela Cell Line, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hela cell line/product/Genecopoeia
Average 95 stars, based on 1 article reviews
hela cell line - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
Korean Cell Line Bank hela human negroid cervix epitheloid carcinoma
ZP3-Cancer is the dominant transcript in tumor cells and is differentially distributed among cancer types. (A) Expression of the seven annotated ZP3 transcripts in CCls (n=1339). Bars represent Tukey box plots (boxes are median+IQR). Median transcript expression levels (from left to right) are 2.47, 0.22, 0.0, 0.04, 0.42, 0.0 and 0.0 TPM. ZP3-Cancer expression is significantly higher compared to all other transcripts (Kruskal-Wallis test, p < 0.0001). NC = Non-protein coding. (B) Relative expression of ZP3-cancer and ZP3-Oocyte in the <t>CCLs</t> <t>MCF7</t> and <t>HeLa,</t> and in healthy ovarian tissue containing follicles, as determined by qPCR. ZP3-Cancer expression is set to 1 for MCF7 and HeLa, ZP3-Oocyte expression is set to 1 for ovarian tissue. ‘ZP3-both’ served as a positive control and used primers designed to detect ZP3-Cancer and ZP3-Oocyte simultaneously. Bars represent mean+SD for the triplicate qPCR reactions. (C) Differential expression of ZP3-Cancer in the cancer types covered by the CCLs. Cancer types represented by less than 5 CCLs were not included. Bars represent Tukey box plots (boxes are median+IQR). Number of samples are indicated between brackets. The shaded area indicates CCLs with a ZP3-Cancer expression level below the overall median (2.54 TPM).
Hela Human Negroid Cervix Epitheloid Carcinoma, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hela human negroid cervix epitheloid carcinoma/product/Korean Cell Line Bank
Average 90 stars, based on 1 article reviews
hela human negroid cervix epitheloid carcinoma - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dainippon Sumitomo human cervical carcinoma cell line hela
ZP3-Cancer is the dominant transcript in tumor cells and is differentially distributed among cancer types. (A) Expression of the seven annotated ZP3 transcripts in CCls (n=1339). Bars represent Tukey box plots (boxes are median+IQR). Median transcript expression levels (from left to right) are 2.47, 0.22, 0.0, 0.04, 0.42, 0.0 and 0.0 TPM. ZP3-Cancer expression is significantly higher compared to all other transcripts (Kruskal-Wallis test, p < 0.0001). NC = Non-protein coding. (B) Relative expression of ZP3-cancer and ZP3-Oocyte in the <t>CCLs</t> <t>MCF7</t> and <t>HeLa,</t> and in healthy ovarian tissue containing follicles, as determined by qPCR. ZP3-Cancer expression is set to 1 for MCF7 and HeLa, ZP3-Oocyte expression is set to 1 for ovarian tissue. ‘ZP3-both’ served as a positive control and used primers designed to detect ZP3-Cancer and ZP3-Oocyte simultaneously. Bars represent mean+SD for the triplicate qPCR reactions. (C) Differential expression of ZP3-Cancer in the cancer types covered by the CCLs. Cancer types represented by less than 5 CCLs were not included. Bars represent Tukey box plots (boxes are median+IQR). Number of samples are indicated between brackets. The shaded area indicates CCLs with a ZP3-Cancer expression level below the overall median (2.54 TPM).
Human Cervical Carcinoma Cell Line Hela, supplied by Dainippon Sumitomo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical carcinoma cell line hela/product/Dainippon Sumitomo
Average 90 stars, based on 1 article reviews
human cervical carcinoma cell line hela - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
National Centre for Cell Science human cervical adenocarcinoma cell line (hela)
ZP3-Cancer is the dominant transcript in tumor cells and is differentially distributed among cancer types. (A) Expression of the seven annotated ZP3 transcripts in CCls (n=1339). Bars represent Tukey box plots (boxes are median+IQR). Median transcript expression levels (from left to right) are 2.47, 0.22, 0.0, 0.04, 0.42, 0.0 and 0.0 TPM. ZP3-Cancer expression is significantly higher compared to all other transcripts (Kruskal-Wallis test, p < 0.0001). NC = Non-protein coding. (B) Relative expression of ZP3-cancer and ZP3-Oocyte in the <t>CCLs</t> <t>MCF7</t> and <t>HeLa,</t> and in healthy ovarian tissue containing follicles, as determined by qPCR. ZP3-Cancer expression is set to 1 for MCF7 and HeLa, ZP3-Oocyte expression is set to 1 for ovarian tissue. ‘ZP3-both’ served as a positive control and used primers designed to detect ZP3-Cancer and ZP3-Oocyte simultaneously. Bars represent mean+SD for the triplicate qPCR reactions. (C) Differential expression of ZP3-Cancer in the cancer types covered by the CCLs. Cancer types represented by less than 5 CCLs were not included. Bars represent Tukey box plots (boxes are median+IQR). Number of samples are indicated between brackets. The shaded area indicates CCLs with a ZP3-Cancer expression level below the overall median (2.54 TPM).
Human Cervical Adenocarcinoma Cell Line (Hela), supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical adenocarcinoma cell line (hela)/product/National Centre for Cell Science
Average 90 stars, based on 1 article reviews
human cervical adenocarcinoma cell line (hela) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Ubigene Biosciences Co Ltd human cervical squamous cell carcinoma cell lines hela pkm ko
ZP3-Cancer is the dominant transcript in tumor cells and is differentially distributed among cancer types. (A) Expression of the seven annotated ZP3 transcripts in CCls (n=1339). Bars represent Tukey box plots (boxes are median+IQR). Median transcript expression levels (from left to right) are 2.47, 0.22, 0.0, 0.04, 0.42, 0.0 and 0.0 TPM. ZP3-Cancer expression is significantly higher compared to all other transcripts (Kruskal-Wallis test, p < 0.0001). NC = Non-protein coding. (B) Relative expression of ZP3-cancer and ZP3-Oocyte in the <t>CCLs</t> <t>MCF7</t> and <t>HeLa,</t> and in healthy ovarian tissue containing follicles, as determined by qPCR. ZP3-Cancer expression is set to 1 for MCF7 and HeLa, ZP3-Oocyte expression is set to 1 for ovarian tissue. ‘ZP3-both’ served as a positive control and used primers designed to detect ZP3-Cancer and ZP3-Oocyte simultaneously. Bars represent mean+SD for the triplicate qPCR reactions. (C) Differential expression of ZP3-Cancer in the cancer types covered by the CCLs. Cancer types represented by less than 5 CCLs were not included. Bars represent Tukey box plots (boxes are median+IQR). Number of samples are indicated between brackets. The shaded area indicates CCLs with a ZP3-Cancer expression level below the overall median (2.54 TPM).
Human Cervical Squamous Cell Carcinoma Cell Lines Hela Pkm Ko, supplied by Ubigene Biosciences Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical squamous cell carcinoma cell lines hela pkm ko/product/Ubigene Biosciences Co Ltd
Average 90 stars, based on 1 article reviews
human cervical squamous cell carcinoma cell lines hela pkm ko - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
European Collection of Authenticated Cell Cultures human cervix carcinoma (hela) cell line
ZP3-Cancer is the dominant transcript in tumor cells and is differentially distributed among cancer types. (A) Expression of the seven annotated ZP3 transcripts in CCls (n=1339). Bars represent Tukey box plots (boxes are median+IQR). Median transcript expression levels (from left to right) are 2.47, 0.22, 0.0, 0.04, 0.42, 0.0 and 0.0 TPM. ZP3-Cancer expression is significantly higher compared to all other transcripts (Kruskal-Wallis test, p < 0.0001). NC = Non-protein coding. (B) Relative expression of ZP3-cancer and ZP3-Oocyte in the <t>CCLs</t> <t>MCF7</t> and <t>HeLa,</t> and in healthy ovarian tissue containing follicles, as determined by qPCR. ZP3-Cancer expression is set to 1 for MCF7 and HeLa, ZP3-Oocyte expression is set to 1 for ovarian tissue. ‘ZP3-both’ served as a positive control and used primers designed to detect ZP3-Cancer and ZP3-Oocyte simultaneously. Bars represent mean+SD for the triplicate qPCR reactions. (C) Differential expression of ZP3-Cancer in the cancer types covered by the CCLs. Cancer types represented by less than 5 CCLs were not included. Bars represent Tukey box plots (boxes are median+IQR). Number of samples are indicated between brackets. The shaded area indicates CCLs with a ZP3-Cancer expression level below the overall median (2.54 TPM).
Human Cervix Carcinoma (Hela) Cell Line, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervix carcinoma (hela) cell line/product/European Collection of Authenticated Cell Cultures
Average 90 stars, based on 1 article reviews
human cervix carcinoma (hela) cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
BioVector NTCC human cervical cancer hela cell line
ZP3-Cancer is the dominant transcript in tumor cells and is differentially distributed among cancer types. (A) Expression of the seven annotated ZP3 transcripts in CCls (n=1339). Bars represent Tukey box plots (boxes are median+IQR). Median transcript expression levels (from left to right) are 2.47, 0.22, 0.0, 0.04, 0.42, 0.0 and 0.0 TPM. ZP3-Cancer expression is significantly higher compared to all other transcripts (Kruskal-Wallis test, p < 0.0001). NC = Non-protein coding. (B) Relative expression of ZP3-cancer and ZP3-Oocyte in the <t>CCLs</t> <t>MCF7</t> and <t>HeLa,</t> and in healthy ovarian tissue containing follicles, as determined by qPCR. ZP3-Cancer expression is set to 1 for MCF7 and HeLa, ZP3-Oocyte expression is set to 1 for ovarian tissue. ‘ZP3-both’ served as a positive control and used primers designed to detect ZP3-Cancer and ZP3-Oocyte simultaneously. Bars represent mean+SD for the triplicate qPCR reactions. (C) Differential expression of ZP3-Cancer in the cancer types covered by the CCLs. Cancer types represented by less than 5 CCLs were not included. Bars represent Tukey box plots (boxes are median+IQR). Number of samples are indicated between brackets. The shaded area indicates CCLs with a ZP3-Cancer expression level below the overall median (2.54 TPM).
Human Cervical Cancer Hela Cell Line, supplied by BioVector NTCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer hela cell line/product/BioVector NTCC
Average 90 stars, based on 1 article reviews
human cervical cancer hela cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
China Center for Type Culture Collection human hela cells gdc0009
Knockdown of FLNB promotes proliferation and inhibits apoptosis of <t>HeLa</t> <t>cells.</t> (A) Relative mRNA expression of FLNB in HeLa cells after it was knocked down using FLNB -specific shRNA was determined by reverse transcription-qPCR. shFLNB_1 and shFLNB_2 indicate two biological repeats of HeLa cells transfected with FLNB-specific shRNA. Ctrl_1 and Ctrl_2 indicate two biological repeats of HeLa cells transfected with empty vector as controls. (B) Cell proliferation of shFLNB was measured by an MTT assay in HeLa cells. Cell apoptosis of cells transfected with shFLNB was measured by (C) flow cytometry and (D) subsequent analysis by a 7-ADD and Annexin V assay. *P<0.05 and **P<0.01 vs. respective Ctrl. FLNB , filamin B; sh, short hairpin; qPCR, quantitative PCR; Ctrl, control; 7-AAD, 7-amino actinomycin D; OD, optical density; PE, phycoerythrin.
Human Hela Cells Gdc0009, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human hela cells gdc0009/product/China Center for Type Culture Collection
Average 90 stars, based on 1 article reviews
human hela cells gdc0009 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
DS Pharma Biomedical human cervical cancer cell line hela
Knockdown of FLNB promotes proliferation and inhibits apoptosis of <t>HeLa</t> <t>cells.</t> (A) Relative mRNA expression of FLNB in HeLa cells after it was knocked down using FLNB -specific shRNA was determined by reverse transcription-qPCR. shFLNB_1 and shFLNB_2 indicate two biological repeats of HeLa cells transfected with FLNB-specific shRNA. Ctrl_1 and Ctrl_2 indicate two biological repeats of HeLa cells transfected with empty vector as controls. (B) Cell proliferation of shFLNB was measured by an MTT assay in HeLa cells. Cell apoptosis of cells transfected with shFLNB was measured by (C) flow cytometry and (D) subsequent analysis by a 7-ADD and Annexin V assay. *P<0.05 and **P<0.01 vs. respective Ctrl. FLNB , filamin B; sh, short hairpin; qPCR, quantitative PCR; Ctrl, control; 7-AAD, 7-amino actinomycin D; OD, optical density; PE, phycoerythrin.
Human Cervical Cancer Cell Line Hela, supplied by DS Pharma Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer cell line hela/product/DS Pharma Biomedical
Average 90 stars, based on 1 article reviews
human cervical cancer cell line hela - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
iCell Bioscience Inc human cesc cell lines hela
The expression of transforming growth factor α (TGFA) in different patients was analysed by bioinformatics and immunohistochemistry. (A) TGFA expression difference analysis results of 33 tumours based on TCGA database data. (B) Pan‐cancer analysis of paired samples based on TCGA database data. (C) Differential analysis of TGFA expression in unpaired cervical squamous cell carcinoma and endocervical adenocarcinoma <t>(CESC)</t> samples. (D) Differential analysis of TGFA expression in paired CESC samples. (E) TGFA expression differential analysis based on GSE6791 data. (F) TGFA expression differential analysis based on GSE7410 data. (G) Immunohistochemical results of TGFA in normal cervical tissues and cervical squamous cell carcinoma with different degrees of differentiation. (H) Immunohistochemical results of TGFA in normal and adenocarcinoma tissues of the cervix. (I) Group comparison of TGFA immunohistochemical results in 16 normal cervical tissues, 6 precancerous lesions (CIN‐III), and 42 CESC tissues. Significance identifier: ns (no significance), p ≥ 0.05; *, p < 0.05; ** p < 0.01; *** p < 0.001.
Human Cesc Cell Lines Hela, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cesc cell lines hela/product/iCell Bioscience Inc
Average 90 stars, based on 1 article reviews
human cesc cell lines hela - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


ZP3-Cancer is the dominant transcript in tumor cells and is differentially distributed among cancer types. (A) Expression of the seven annotated ZP3 transcripts in CCls (n=1339). Bars represent Tukey box plots (boxes are median+IQR). Median transcript expression levels (from left to right) are 2.47, 0.22, 0.0, 0.04, 0.42, 0.0 and 0.0 TPM. ZP3-Cancer expression is significantly higher compared to all other transcripts (Kruskal-Wallis test, p < 0.0001). NC = Non-protein coding. (B) Relative expression of ZP3-cancer and ZP3-Oocyte in the CCLs MCF7 and HeLa, and in healthy ovarian tissue containing follicles, as determined by qPCR. ZP3-Cancer expression is set to 1 for MCF7 and HeLa, ZP3-Oocyte expression is set to 1 for ovarian tissue. ‘ZP3-both’ served as a positive control and used primers designed to detect ZP3-Cancer and ZP3-Oocyte simultaneously. Bars represent mean+SD for the triplicate qPCR reactions. (C) Differential expression of ZP3-Cancer in the cancer types covered by the CCLs. Cancer types represented by less than 5 CCLs were not included. Bars represent Tukey box plots (boxes are median+IQR). Number of samples are indicated between brackets. The shaded area indicates CCLs with a ZP3-Cancer expression level below the overall median (2.54 TPM).

Journal: Frontiers in Oncology

Article Title: A tumor cell specific Zona Pellucida glycoprotein 3 RNA transcript encodes an intracellular cancer antigen

doi: 10.3389/fonc.2023.1233039

Figure Lengend Snippet: ZP3-Cancer is the dominant transcript in tumor cells and is differentially distributed among cancer types. (A) Expression of the seven annotated ZP3 transcripts in CCls (n=1339). Bars represent Tukey box plots (boxes are median+IQR). Median transcript expression levels (from left to right) are 2.47, 0.22, 0.0, 0.04, 0.42, 0.0 and 0.0 TPM. ZP3-Cancer expression is significantly higher compared to all other transcripts (Kruskal-Wallis test, p < 0.0001). NC = Non-protein coding. (B) Relative expression of ZP3-cancer and ZP3-Oocyte in the CCLs MCF7 and HeLa, and in healthy ovarian tissue containing follicles, as determined by qPCR. ZP3-Cancer expression is set to 1 for MCF7 and HeLa, ZP3-Oocyte expression is set to 1 for ovarian tissue. ‘ZP3-both’ served as a positive control and used primers designed to detect ZP3-Cancer and ZP3-Oocyte simultaneously. Bars represent mean+SD for the triplicate qPCR reactions. (C) Differential expression of ZP3-Cancer in the cancer types covered by the CCLs. Cancer types represented by less than 5 CCLs were not included. Bars represent Tukey box plots (boxes are median+IQR). Number of samples are indicated between brackets. The shaded area indicates CCLs with a ZP3-Cancer expression level below the overall median (2.54 TPM).

Article Snippet: Total RNA extracted from the breast cancer cell line MCF7 (R1255830-50) and the cervical cancer cell line HeLa (R1255811-50) was purchased from Amsbio (Abingdon, UK).

Techniques: Expressing, Positive Control

Knockdown of FLNB promotes proliferation and inhibits apoptosis of HeLa cells. (A) Relative mRNA expression of FLNB in HeLa cells after it was knocked down using FLNB -specific shRNA was determined by reverse transcription-qPCR. shFLNB_1 and shFLNB_2 indicate two biological repeats of HeLa cells transfected with FLNB-specific shRNA. Ctrl_1 and Ctrl_2 indicate two biological repeats of HeLa cells transfected with empty vector as controls. (B) Cell proliferation of shFLNB was measured by an MTT assay in HeLa cells. Cell apoptosis of cells transfected with shFLNB was measured by (C) flow cytometry and (D) subsequent analysis by a 7-ADD and Annexin V assay. *P<0.05 and **P<0.01 vs. respective Ctrl. FLNB , filamin B; sh, short hairpin; qPCR, quantitative PCR; Ctrl, control; 7-AAD, 7-amino actinomycin D; OD, optical density; PE, phycoerythrin.

Journal: Oncology Reports

Article Title: Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells

doi: 10.3892/or.2020.7532

Figure Lengend Snippet: Knockdown of FLNB promotes proliferation and inhibits apoptosis of HeLa cells. (A) Relative mRNA expression of FLNB in HeLa cells after it was knocked down using FLNB -specific shRNA was determined by reverse transcription-qPCR. shFLNB_1 and shFLNB_2 indicate two biological repeats of HeLa cells transfected with FLNB-specific shRNA. Ctrl_1 and Ctrl_2 indicate two biological repeats of HeLa cells transfected with empty vector as controls. (B) Cell proliferation of shFLNB was measured by an MTT assay in HeLa cells. Cell apoptosis of cells transfected with shFLNB was measured by (C) flow cytometry and (D) subsequent analysis by a 7-ADD and Annexin V assay. *P<0.05 and **P<0.01 vs. respective Ctrl. FLNB , filamin B; sh, short hairpin; qPCR, quantitative PCR; Ctrl, control; 7-AAD, 7-amino actinomycin D; OD, optical density; PE, phycoerythrin.

Article Snippet: Human HeLa cells (CCTCC@GDC0009) were obtained from The China Center for Type Culture Collection.

Techniques: Knockdown, Expressing, shRNA, Reverse Transcription, Transfection, Plasmid Preparation, MTT Assay, Flow Cytometry, Annexin V Assay, Real-time Polymerase Chain Reaction, Control

GO and KEGG analysis of differentially expressed genes between short hairpin FLNB-transfected and control HeLa cells. Top 10 most enriched GO terms (biological process) of (A) upregulated and (B) downregulated genes upon FLNB knockdown. Rectangles around GO terms indicate notable cancer-related and cartilage development terms. Top 10 most enriched KEGG pathways of (C) upregulated and (D) downregulated genes upon FLNB knockdown. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; FLNB , filamin B.

Journal: Oncology Reports

Article Title: Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells

doi: 10.3892/or.2020.7532

Figure Lengend Snippet: GO and KEGG analysis of differentially expressed genes between short hairpin FLNB-transfected and control HeLa cells. Top 10 most enriched GO terms (biological process) of (A) upregulated and (B) downregulated genes upon FLNB knockdown. Rectangles around GO terms indicate notable cancer-related and cartilage development terms. Top 10 most enriched KEGG pathways of (C) upregulated and (D) downregulated genes upon FLNB knockdown. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; FLNB , filamin B.

Article Snippet: Human HeLa cells (CCTCC@GDC0009) were obtained from The China Center for Type Culture Collection.

Techniques: Transfection, Control, Knockdown

Validation of FLNB -regulated genes (DEGs). (A) Relative expression level (FPKM, up) and RT-qPCR measurement (down) of cartilage development-related DEGs. (B) Related expression level (FPKM, up) and RT-qPCR measurement (down) of apoptotic-related DEGs. (C) Western blot analysis of two apoptotic-related proteins in shFLNB and Ctrl HeLa cells. FLNB , filamin B; DEGs, differentially expressed genes; FPKM, fragments per kilobase of transcript per million fragments mapped; RT-qPCR, reverse transcription-quantitative PCR; sh, short hairpin; Ctrl, control; ATP7A, ATPase copper transporting α; BMP7, bone morphogenetic protein 7; COL2A1, collagen type II α 1 chain; MMP13, matrix metallopeptidase 13; IL23A, interleukin 23 subunit α; MALAT1, metastasis associated lung adenocarcinoma transcript 1; NAIP, NLR family apoptosis inhibitory protein; SLC25A36, solute carrier family 25 member 36; MAP2K7, mitogen-activated protein kinase kinase 7.

Journal: Oncology Reports

Article Title: Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells

doi: 10.3892/or.2020.7532

Figure Lengend Snippet: Validation of FLNB -regulated genes (DEGs). (A) Relative expression level (FPKM, up) and RT-qPCR measurement (down) of cartilage development-related DEGs. (B) Related expression level (FPKM, up) and RT-qPCR measurement (down) of apoptotic-related DEGs. (C) Western blot analysis of two apoptotic-related proteins in shFLNB and Ctrl HeLa cells. FLNB , filamin B; DEGs, differentially expressed genes; FPKM, fragments per kilobase of transcript per million fragments mapped; RT-qPCR, reverse transcription-quantitative PCR; sh, short hairpin; Ctrl, control; ATP7A, ATPase copper transporting α; BMP7, bone morphogenetic protein 7; COL2A1, collagen type II α 1 chain; MMP13, matrix metallopeptidase 13; IL23A, interleukin 23 subunit α; MALAT1, metastasis associated lung adenocarcinoma transcript 1; NAIP, NLR family apoptosis inhibitory protein; SLC25A36, solute carrier family 25 member 36; MAP2K7, mitogen-activated protein kinase kinase 7.

Article Snippet: Human HeLa cells (CCTCC@GDC0009) were obtained from The China Center for Type Culture Collection.

Techniques: Biomarker Discovery, Expressing, Quantitative RT-PCR, Western Blot, Reverse Transcription, Real-time Polymerase Chain Reaction, Control

Validation of FLNB -affected ASEs. Genome visualization (left panel) shows FLNB -regulated ASEs in shFLNB and control. (A) Validation of an ASE of VDR in HeLa cells. (B) Validation of an ASE of PACS2 in HeLa cells. (C) Validation of an ASE of MAP2K7 in HeLa cells. (D) Validation of an ASE of MALAT1 in HeLa cells. The number of junction reads were marked on the line representing splice junction composing ASE. The structures of ASEs are depicted in the top-right panel. The altered ratio of ASEs in RNA-sequencing and in reverse transcription-quantitative PCR were calculated and plotted (right panel, bottom). FLNB , filamin B; ASEs, alternative splicing events; sh/SH, short hairpin; NC, negative control; VDR, vitamin D receptor; PACS2, phosphofurin acidic cluster sorting protein 2; MAP2K7, mitogen-activated protein kinase kinase 7; MALAT1, metastasis associated lung adenocarcinoma transcript 1. *P<0.05 and ***P<0.001 vs. respectively NC.

Journal: Oncology Reports

Article Title: Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells

doi: 10.3892/or.2020.7532

Figure Lengend Snippet: Validation of FLNB -affected ASEs. Genome visualization (left panel) shows FLNB -regulated ASEs in shFLNB and control. (A) Validation of an ASE of VDR in HeLa cells. (B) Validation of an ASE of PACS2 in HeLa cells. (C) Validation of an ASE of MAP2K7 in HeLa cells. (D) Validation of an ASE of MALAT1 in HeLa cells. The number of junction reads were marked on the line representing splice junction composing ASE. The structures of ASEs are depicted in the top-right panel. The altered ratio of ASEs in RNA-sequencing and in reverse transcription-quantitative PCR were calculated and plotted (right panel, bottom). FLNB , filamin B; ASEs, alternative splicing events; sh/SH, short hairpin; NC, negative control; VDR, vitamin D receptor; PACS2, phosphofurin acidic cluster sorting protein 2; MAP2K7, mitogen-activated protein kinase kinase 7; MALAT1, metastasis associated lung adenocarcinoma transcript 1. *P<0.05 and ***P<0.001 vs. respectively NC.

Article Snippet: Human HeLa cells (CCTCC@GDC0009) were obtained from The China Center for Type Culture Collection.

Techniques: Biomarker Discovery, Control, RNA Sequencing, Reverse Transcription, Real-time Polymerase Chain Reaction, Alternative Splicing, Negative Control

The expression of transforming growth factor α (TGFA) in different patients was analysed by bioinformatics and immunohistochemistry. (A) TGFA expression difference analysis results of 33 tumours based on TCGA database data. (B) Pan‐cancer analysis of paired samples based on TCGA database data. (C) Differential analysis of TGFA expression in unpaired cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) samples. (D) Differential analysis of TGFA expression in paired CESC samples. (E) TGFA expression differential analysis based on GSE6791 data. (F) TGFA expression differential analysis based on GSE7410 data. (G) Immunohistochemical results of TGFA in normal cervical tissues and cervical squamous cell carcinoma with different degrees of differentiation. (H) Immunohistochemical results of TGFA in normal and adenocarcinoma tissues of the cervix. (I) Group comparison of TGFA immunohistochemical results in 16 normal cervical tissues, 6 precancerous lesions (CIN‐III), and 42 CESC tissues. Significance identifier: ns (no significance), p ≥ 0.05; *, p < 0.05; ** p < 0.01; *** p < 0.001.

Journal: Journal of Cellular and Molecular Medicine

Article Title: TGFA expression is associated with poor prognosis and promotes the development of cervical cancer

doi: 10.1111/jcmm.18086

Figure Lengend Snippet: The expression of transforming growth factor α (TGFA) in different patients was analysed by bioinformatics and immunohistochemistry. (A) TGFA expression difference analysis results of 33 tumours based on TCGA database data. (B) Pan‐cancer analysis of paired samples based on TCGA database data. (C) Differential analysis of TGFA expression in unpaired cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) samples. (D) Differential analysis of TGFA expression in paired CESC samples. (E) TGFA expression differential analysis based on GSE6791 data. (F) TGFA expression differential analysis based on GSE7410 data. (G) Immunohistochemical results of TGFA in normal cervical tissues and cervical squamous cell carcinoma with different degrees of differentiation. (H) Immunohistochemical results of TGFA in normal and adenocarcinoma tissues of the cervix. (I) Group comparison of TGFA immunohistochemical results in 16 normal cervical tissues, 6 precancerous lesions (CIN‐III), and 42 CESC tissues. Significance identifier: ns (no significance), p ≥ 0.05; *, p < 0.05; ** p < 0.01; *** p < 0.001.

Article Snippet: iCell Bioscience Inc., Shanghai, provided the human CESC cell lines HeLa and SiHa.

Techniques: Expressing, Immunohistochemistry, Immunohistochemical staining, Comparison

Influence of transforming growth factor α (TGFA) expression in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) on diagnosis and prognosis of patients. (A) TGFA diagnostic ROC curve; the area under the ROC curve is between 0.5 and 1. The closer the AUC is to 1, the better the diagnostic effect. When the AUC is between 0.5 and 0.7, the accuracy is low, when the AUC is between 0.7 and 0.9, the accuracy is moderate, and when the AUC is above 0.9, the accuracy is high. (B, C) Clinical significance of TGFA expression with age and menopausal status. (D–F) Stratified KM survival curves for overall survival (OS), disease‐specific survival (DSS), and progression‐free period (PFI) based on TGFA expression. (G) Binary logistic regression analysis results of correlation between TGFA expression level and clinical features in 58 patients. The data is incomplete because some records are missing. Significance identifier: ns (no significance), p ≥ 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

Journal: Journal of Cellular and Molecular Medicine

Article Title: TGFA expression is associated with poor prognosis and promotes the development of cervical cancer

doi: 10.1111/jcmm.18086

Figure Lengend Snippet: Influence of transforming growth factor α (TGFA) expression in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) on diagnosis and prognosis of patients. (A) TGFA diagnostic ROC curve; the area under the ROC curve is between 0.5 and 1. The closer the AUC is to 1, the better the diagnostic effect. When the AUC is between 0.5 and 0.7, the accuracy is low, when the AUC is between 0.7 and 0.9, the accuracy is moderate, and when the AUC is above 0.9, the accuracy is high. (B, C) Clinical significance of TGFA expression with age and menopausal status. (D–F) Stratified KM survival curves for overall survival (OS), disease‐specific survival (DSS), and progression‐free period (PFI) based on TGFA expression. (G) Binary logistic regression analysis results of correlation between TGFA expression level and clinical features in 58 patients. The data is incomplete because some records are missing. Significance identifier: ns (no significance), p ≥ 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

Article Snippet: iCell Bioscience Inc., Shanghai, provided the human CESC cell lines HeLa and SiHa.

Techniques: Expressing, Biomarker Discovery, Diagnostic Assay

Functional validation of TGFA in CESC cell lines. (A) Fluorescence maps of lentivirus transfected HeLa and SiHa cells. (B) HeLa and SiHa cells were transfected with shTGFA, and the expression level of TGFA was detected by qRT‐PCR. (C, D) The proliferation of HeLa and SiHa cells was detected by CCK‐8. (E–G) The ability of HeLa and SiHa cells to metastasize was examined by wound healing assay. Significance identifier: ns (no significance), p ≥ 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

Journal: Journal of Cellular and Molecular Medicine

Article Title: TGFA expression is associated with poor prognosis and promotes the development of cervical cancer

doi: 10.1111/jcmm.18086

Figure Lengend Snippet: Functional validation of TGFA in CESC cell lines. (A) Fluorescence maps of lentivirus transfected HeLa and SiHa cells. (B) HeLa and SiHa cells were transfected with shTGFA, and the expression level of TGFA was detected by qRT‐PCR. (C, D) The proliferation of HeLa and SiHa cells was detected by CCK‐8. (E–G) The ability of HeLa and SiHa cells to metastasize was examined by wound healing assay. Significance identifier: ns (no significance), p ≥ 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

Article Snippet: iCell Bioscience Inc., Shanghai, provided the human CESC cell lines HeLa and SiHa.

Techniques: Functional Assay, Biomarker Discovery, Fluorescence, Transfection, Expressing, Quantitative RT-PCR, CCK-8 Assay, Wound Healing Assay

Functional validation of TGFA in CESC cell lines. (A, C) The proliferation of HeLa and SiHa cells was detected by colony formation assay. (B, D) The invasion ability of HeLa and SiHa cells was detected by Transwell assay. (E–G) The expression of IL‐1A, IL‐17, MMP1, MMP10 and MMP13 after TGFA expression reduction was detected by western blot. Significance identifier: ns (no significance), p ≥ 0.05; *, p < 0.05; ** p < 0.01; *** p < 0.001.

Journal: Journal of Cellular and Molecular Medicine

Article Title: TGFA expression is associated with poor prognosis and promotes the development of cervical cancer

doi: 10.1111/jcmm.18086

Figure Lengend Snippet: Functional validation of TGFA in CESC cell lines. (A, C) The proliferation of HeLa and SiHa cells was detected by colony formation assay. (B, D) The invasion ability of HeLa and SiHa cells was detected by Transwell assay. (E–G) The expression of IL‐1A, IL‐17, MMP1, MMP10 and MMP13 after TGFA expression reduction was detected by western blot. Significance identifier: ns (no significance), p ≥ 0.05; *, p < 0.05; ** p < 0.01; *** p < 0.001.

Article Snippet: iCell Bioscience Inc., Shanghai, provided the human CESC cell lines HeLa and SiHa.

Techniques: Functional Assay, Biomarker Discovery, Colony Assay, Transwell Assay, Expressing, Western Blot